Everything We’re Saying, and Everything Being Said About Us
Explore the stories behind our science and the people it serves.
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and new research on inclusive oncology AI.
Highlight of the Month
PAICON and NVIDIA Spotlight Sovereign AI at AI Week
PAICON and NVIDIA jointly highlighted the future of Sovereign AI at AI Week.
PAICON’s Partnership with UKHD and DKFZ
In an ever-evolving healthcare landscape, continuous collaboration is key to driving meaningful advancements.
EU AI Act Enacted: New Rules for AI Risk and Oversight
The EU AI Act, introduced in June 2023, is a significant milestone in regulating artificial intelligence within the European Union....
PAICON Exhibited at NLS 2023 in Copenhagen
PAICON stepped onto the stage at the Nordic Life Science Days on 29–30 November 2023, which is one of the...
Insights on Keynote Lecture at EuroSTEMPeers 2023
Dr. Manasi Aichmüller-Ratnaparkhe, co-founder of PAICON, was a featured speaker at EuroSTEMPeers on 3 June 2023, which is an influential...
Bertelsmann Investments Becomes Shareholder in Digital Health Start-up Alongside German Cancer Research Center
tersloh / Heidelberg, November 17, 2022 – Bertelsmann Investments has acquired shares in PAICON, a Heidelberg-based digital health start-up. Other...
Subscribe to Our Monthly Newsletter
Each month, we will send key data updates, stories from the field, and
new research on
inclusive oncology AI.